PMC:7228307 / 56847-57109
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1164 | 127-134 | Gene | denotes | FcγRIIa | Gene:2212 |
1165 | 162-170 | Species | denotes | patients | Tax:9606 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T957 | 73-75 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T958 | 95-96 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T959 | 127-129 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
1164 | 127-134 | Gene | denotes | FcγRIIa | Gene:2212 |
1165 | 162-170 | Species | denotes | patients | Tax:9606 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T316 | 0-262 | Sentence | denotes | Thus, antibodies modified with “SELF” have very‐high‐affinity binding to FcγRIIa‐R131 115 with a potentially increased risk of FcγRIIa‐dependent complications in patients expressing this allelic form, although, so far, none have been reported in clinical trials. |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T316 | 0-262 | Sentence | denotes | Thus, antibodies modified with “SELF” have very‐high‐affinity binding to FcγRIIa‐R131 115 with a potentially increased risk of FcγRIIa‐dependent complications in patients expressing this allelic form, although, so far, none have been reported in clinical trials. |